ArticleJournal of vascular surgery cases and innovative techniques2026
Hybrid surgical and endovascular management of severe gastrointestinal hemorrhage from mesenteric arteriovenous malformation.
Article in Journal of vascular surgery cases and innovative techniques, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An unusual superior mesenteric arteriovenous malformation causing obscure gastrointestinal bleeding: a case report.BMC gastroenterology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mesenteric arteriovenous malformation is a rare vascular anomaly that can worsen portal hypertension and cause life-threatening gastrointestinal bleeding. We report a 37-year-old man with chronic portal and mesenteric vein thrombosis who presented with recurrent hematochezia refractory to endoscopic and medical therapy. Imaging demonstrated diffuse mesenteric arteriovenous malformation with venous congestion. A staged hybrid strategy was performed: selective embolization reduced shunt flow, followed by bowel resection and creation of a mesocaval shunt. Histopathology confirmed extensive venous abnormalities. The patient recovered uneventfully, and no recurrent bleeding occurred during 9 months of follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.